[MTX/5FU sequential therapy for advanced and recurrent gastric cancer].
Murakami
M
M
Department of Hematology and Chemotherapy, Aichi Cancer Center.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005493:Folic Acid Antagonists / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011788:Quality of Life; D012264:Ribonucleotide Reductases / Q000502:physiology; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*; D013940:Thymidylate Synthase / Q000378:metabolism; D016896:Treatment Outcome
D005493:Folic Acid Antagonists; D012264:Ribonucleotide Reductases; D013940:Thymidylate Synthase; D005472:Fluorouracil; D008727:Methotrexate